$23.34
-1.31-5.31%
Last update: 1:54 PM
15 minutes delayed
TG Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TG Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0.04 | $-0.05 | 180.0 % |
Mar 2024 | 2024-05-01 | $-0.07 | $-0.04 | -75.0 % |
Dec 2023 | 2024-02-28 | $-0.09 | $-0.10 | 10.0 % |
Sep 2023 | 2023-11-01 | $0.73 | $0.12 | 508.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $73.47M | $65.89M | 11.5 % |
Mar 2024 | 2024-05-01 | $63.47M | $54.58M | 16.3 % |
Dec 2023 | 2024-02-28 | $43.97M | $40.06M | 9.76 % |
Sep 2023 | 2023-11-01 | $165.82M | $46.56M | 256.1 % |
TG Therapeutics (TGTX) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $0.04, which beat the estimate of $-0.05.
The Actual Revenue was $73.5M, which beat the estimate of $65.9M.
Browse earnings estimates, EPS, and revenue on all stocks.